Compounds and compositions as protein kinase inhibitors

Details Compounds and compositions as protein kinase inhibitors Compounds and compositions as protein kinase inhibitors

C - Chemistry, Metallurgy

07

D

C07D 215/16 (2006.01) A61K 31/44 (2006.01) A61K 31/47 (2006.01) A61K 31/519 (2006.01) C07D 471/00 (2006.01) C07D 471/02 (2006.01)

Patent

CA 2542105

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, BCR-Abl, CSK, JNK1, JNK2, PDGF-R, p38, p70S6K, TGF.beta., SRC, EGFR, c-Kit, trkB, FGFR3, Fes, Lck, Syk, RAF, MKK4, MKK6 and SAPK2.beta. kinases. The novel class of compounds relates to a compound of Formula I: (see formula I) in which: n is 0, 1 or 2; Y is selected from -C(H)= and -N=; Z is selected from -C(H)= and N=; R1 is selected from hydrogen, halo and -R4; R2 is selected from hydrogen and C1-6alkyl; R3 is selected from halo, nitro, C1-6alkyl and C1-6alkoxy; R4 is selected from C3-8heterocycloalkyl, - NR5R6, -XNR5C(O)R6, --XC(O)NR5R6 and -XNR5S(O)0-2R6; wherein X is a bond or C1-4alkylene; R5 is selected from hydrogen and C1-6alkyl; R6 is selected from C1-6alkyl, C6-10aryl-C0-4alkyl, C5-10heteroaryl-C0-4alkyl, C3-12cycloalkyl-C0-4alkyl and C3-8heterocycloalkyl- C0-4alkyl; wherein any aryl, heteroaryl, cycloalkyl and heterocycloalkyl of R4 is optionally substituted by 1 to 3 radicals independently selected from halo, hydroxy, nitro, cyano, C1-6alkyl optionally substituted with hydroxy, C1-6alkoxy, halo-substituted-C1-6alkyl, halo-substituted-C1- 6alkoxy, --XOXNR7R8, -XS(O)0-2R7, -XS(O)0-2NR7R8, -XOR7, -XC(O)NR7R8, XNR7R8, -XNR7S(O)0-2R7 and -XR9; wherein X is a bond or C1-4alkylene; R7 and R8 are independently selected from hydrogen and C1-6alkyl; R9 is selected from C6-10aryl, C5- 10heteroaryl C3--12cycloalkyl and C3-8heterocycloalkyl; wherein any aryl, heteroaryl, cycloalkyl or heterocycloalkyl of R9 is optionally substituted with 1 to 3 C1-6alkyl radicals; R10 is selected from hydrogen, halo and C1-6alkyl; or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof.

La présente invention concerne une nouvelle classe de composés, des compositions pharmaceutiques comprenant de tels composés, et des procédés pour utiliser de tels composés pour traiter ou prévenir des affections ou troubles en lien avec une activité kinase anormale ou dérégulée, en particulier de maladies ou de troubles impliquant une activation anormale des kinases Abl, BCR-Abl, CSK, JNK1, JNK2, PDGF-R, p38, p70S6K, TGF.beta., SRC, EGFR, c-Kit, trkB, FGFR3, Fes, Lck, Syk, RAF, MKK4, MKK6 et SAPK2.beta..

Affiliated with

Also associated with

Rating

Compounds and compositions as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds and compositions as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and compositions as protein kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1371838